Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL001873

Drug Information
NameElinogrel
CompanyNovartis Pharmaceuticals ; Portola Pharmaceuticals
IndicationAcute coronary syndrome (see also heart attack)
[ICD9: 410, 411.1   ICD10: I20.0, I21, I22]
Phase II    
Myocardial infarction (see also acute coronary syndrome)
[ICD9: 410, 411.1   ICD10: I20.0, I21, I22]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-
14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,
23H,1H3,(H,25,30)(H2,24,26,29)
InChIKeyLGSDFTPAICUONK-UHFFFAOYSA-N
Canonical SMILESCNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)
Cl)F    
CAS NumberCAS 936500-94-6
FormulaC20H15ClFN5O5S2
PubChem Compound IDCID 16066663.



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543